30 October 2015 - The European Commission has approved Vidaza (azacitidine for injection) for the treatment of adult patients aged 65 years or older with acute myeloid leukaemia who are not eligible for haematopoietic stem cell transplantation.

For more details, go to: http://ir.celgene.com/releasedetail.cfm?ReleaseID=939462